Digital health technologies are reshaping respiratory medicine, from home-based monitoring in chronic lung disease to ...

Paul Shawah, EVP, strategy, Veeva Systems and Richard Staub, president, R&D solutions, IQVIA, discuss how their partnership ...

The global virtual clinical trials market is set to witness a growth rate of ~6% in the next 5 years. Rising adoption of decentralized trial models, advancements in digital health technologies, ...

Pharma R&D faces rising trial complexity, high costs, and patient and investigator shortages, driving the need for adaptive models and data-driven strategies to speed therapies to market.

Samsung has partnered with Galeon, allowing anonymized data from its ultrasound devices to be handled and analyzed through a ...

Samsung partners with Galeon, a DeSci and AI protocol, to train AI in a decentralized, privacy-focused mode to enhance ...

Healthcare and life sciences enterprises are using generative AI, agentic AI and analytics to transform patient care and drug ...

IntroductionThe pharmaceutical industry is entering a new era of globalization, where innovation, accessibility, and collaboration define long-term competitiveness. DengYue Medicine, guided by its ...

Gangwon Special Self-Governing Province (Governor Kim Jin-tae) announced on the 25th that it held the "2025 Gangwon AI ...

Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: ...